Silver Book Fact

An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer was suppressed. It is also thought that it may cross the blood-brain barrier, suppressing the spread of breast cancer to the brain.

Pollack A. New Drug Holds Promise for Type of Breast Cancer. The New York Times. June 4 2006. http://www.nytimes.com/2006/06/04/health/04cancer.html?ex=1159329600&en=691f887bb3d95f4b&ei=5070

Reference

Title
New Drug Holds Promise for Type of Breast Cancer
Publication
The New York Times
Publication Date
June 4 2006
Authors
Pollack A
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.  
  • Gains in healthy years of life and social value from cancer R&D
     
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.